Lataa...
Bitter Taste Receptors for Asthma Therapeutics
Clinical management of asthma and chronic obstructive pulmonary disease (COPD) has primarily relied on the use of beta 2 adrenergic receptor agonists (bronchodilators) and corticosteroids, and more recently, monoclonal antibody therapies (biologics) targeting specific cytokines and their functions....
Tallennettuna:
| Julkaisussa: | Front Physiol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6647873/ https://ncbi.nlm.nih.gov/pubmed/31379597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphys.2019.00884 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|